Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 May;130(2):339-44.
doi: 10.1038/sj.bjp.0703310.

Protective effects of cyclosporin-A in splanchnic artery occlusion shock

Affiliations

Protective effects of cyclosporin-A in splanchnic artery occlusion shock

F Squadrito et al. Br J Pharmacol. 2000 May.

Abstract

Cyclosporin A (CsA) is an immunosuppressant drug that inhibits nitric oxide (NO) synthase induction in vascular smooth muscle cells. Splanchnic artery occlusion (SAO) shock is a lethal type of shock characterized by a marked vascular dysfunction in which the L-arginine/nitric oxide pathway plays an important role. We investigated whether CsA exerts protective effects in SAO shock by interfering with the L-arginine/nitric oxide pathway. Male anaesthetized rats (n=156) were subjected to clamping of the splanchnic arteries for 45 min. This surgical procedure resulted in an irreversible state of shock (SAO shock). Sham operated animals were used as controls. SAO shocked rats had a decreased survival (86+/-6 min, while sham shocked rats survived more than 240 min), marked hypotension, increased serum levels of TNF-alpha, enhanced plasma nitrite/nitrate concentrations (75+/-7.1 microM; sham shocked rats=1.6+/-0.5 microM) and enhanced inducible NO synthase (iNOS) protein induction and activity in the aorta. Moreover aortic rings from shocked rats showed a marked hyporeactivity to phenylephrine (PE, 1 nM - 10 microM). CsA (0.25, 0.5 and 1 mg kg(-1), 5 min after reperfusion) increased survival rate (SAO+CsA=236+/-9 min following the highest dose), reverted the marked hypotension, reduced plasma nitrite/nitrate concentration (11+/-5.2 microM following the highest dose), restored to control values the hyporeactivity to PE, and blunted iNOS protein induction and activity in aortic rings. The present data indicate that in an experimental rat model CsA may have antishock properties related to inhibition of L-arginine/nitric oxide pathway.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Contractile response to cumulative doses of phenylephrine (PE) in endothelium denuded aortic rings from sham-operated rats and rats subjected to splanchnic ischaemia-reperfusion injury (SAO) treated with vehicle (1 ml kg−1 i.v, 5 min after the onset of reperfusion), Cyclosporin A (CsA 0.25, 0.50 and 1 mg kg−1 i.v. 5 min following the onset of reperfusion), L-NAME (5 mg kg−1, 5 min following the onset of reperfusion) and 1400 W (20 mg kg−1, 5 min following the onset of reperfusion). Aortae were removed 70 min following the onset of reperfusion. The occlusion period lasted 45 min. Each point represents the mean±s.e.mean of seven experiments. *P<0.05 vs SAO+vehicle. #P<0.01 vs SAO+vehicle.
Figure 2
Figure 2
Effects of vehicle (1 ml kg−1 i.v., 5 min after the onset of reperfusion) or Cyclosporin A (CsA 0.25, 0.50 and 1 mg kg−1 i.v., 5 min following the onset of reperfusion) on serum TNF-α in rats subjected to splanchnic ischaemia-reperfusion injury (SAO). The occlusion period lasted 45 min. Each point represents the mean±s.e. mean of seven experiments. *P<0.01 vs SAO+vehicle; #P<0.001 vs SAO+vehicle.
Figure 3
Figure 3
Effect of vehicle (1 ml kg−1 i.v., 5 min after the onset of reperfusion) or Cyclosporin A (CsA, 1 mg kg−1 5 min after the onset of reperfusion) on the induction of iNOS protein in aortae collected 70 min following the onset of reperfusion in splanchnic artery occlusion (SAO; 45 min of occlusion) shocked rats.

Similar articles

Cited by

References

    1. AKITA K., DUSTING G.J., HICKEY H. Suppression of nitric oxide production by cyclosporin and FK506 in rat vascular smooth muscle cells. Clin. Exp. Pharmacol. Physiol. 1994;21:231–233. - PubMed
    1. ALTAVILLA D., BERLINGHIERI M.C., SEMINARA S., IANNELLO D., FOCA' A., MASTROENI P. Differential effects of bacterial lipopolysaccharide on superoxide anion production by macrophages from normal and tumor bearing rats. Immunopharmacology. 1989;17:99–105. - PubMed
    1. BUSSE R., MULSCH A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS. Lett. 1990;275:87–90. - PubMed
    1. CAPUTI A.P., ROSSI F., CARNEY K., BREZENOFF H.E. Modulatory effect of brain acetylcholine on reflex-induced bradycardia and tachycardia in conscious rats. J. Pharmacol. Exp. Ther. 1980;215:309–316. - PubMed
    1. CLIPSTONE N.A., CRABTREE G.R. Calcineurin is a key signaling enzyme in lymphocyte activation and the target of immunosuppressive drugs cyclosporin A and FK506. Ann. NY. Acad. Sci. 1993;696:20–30. - PubMed